Licenses
DAY3 holds the Eudralex GDP and wholesale authorization according to § 52a of the Medicines Act (AMG) and the Med-cannG license.
Quality
Our quality management is an experienced team of professionals. We also require the same high standards from our suppliers and partners.
Products
We are a full-stack provider of medical cannabinoids. Highest production standards, constant availability and quality of active ingredients.
Day3 Pharmaceuticals Germany GmbH
A licensed pharma distribution company with expertise and focus in medical cannabis.
We are part of an international group spanning along the supply chain of the cannabis market – from R&D through cultivation and processing to multi territory distribution.
Currently in the German market: our very high quality, non-irradiated strain that can be found in various pharmacies
We are distributing products worldwide under the brand name “Briah”, related to the genesis of creation, the craft of God.
Licenses:
DAY3 holds the Eudralex GDP and wholesale authorization according to § 52a of the Medicines Act (AMG) and the Med-cannG license.
As part of an established corporate group in the cannabis sector, we operate along the entire supply chain. Our group includes “Creator Of All LTD” to operate state-of-the-art cultivation facilities, and the top-tier indoor facility “Therapin”, both have been operating in multiple markets successfully, based in Israel, which is the pioneer in medical cannabis science, R&D, and medical legal framework.
In these facilities, we cultivate our own strains, which are now partially available in Germany.
Our products are craft-grown according to the highest industry standards, hang-dried, hand-trimmed, and the buds are cherry-picked to keep the most attractive ones for the German market.
Our international partnerships include a variety of cultivation operations worldwide.
We process our products in certified and regulated EUGMP facilities in the EU.
Quality management
Our quality management is an experienced team of professionals. We also require the same high standards from our suppliers and partners.
Quality management
Our quality management is an experienced team of professionals. We also require the same high standards from our suppliers and partners.
Our Products:
We are a full-stack provider of medical cannabinoids. Highest production standards, constant availability and quality as well as high concentration of active ingredients.
Can I get Medical Cannabis?
To qualify for medical cannabis treatment in Germany, patients must meet specific eligibility criteria outlined in the German Narcotic Drugs Act (BtMG) and the Medical Cannabis Prescription Regulation (Cannabisverordnung). The decision to prescribe medical cannabis is made by a qualified physician and is based on a thorough assessment of the patient’s medical condition. Below are the primary criteria and medical conditions that, by law, can be treated with medical cannabis in Germany:
- Medical Condition Not Responding to Standard Treatments: One of the primary eligibility criteria is that the patient’s medical condition must not be adequately managed or improved with standard treatments.
Getting Reimbursed by Health Insurance
National Health Insurance
If you have national health insurance in Germany, you may be eligible to get reimbursed for the cost of your medical cannabis. However, there are some specific requirements that must be met in order to qualify for reimbursement.
First, your doctor must certify that you have a serious illness and that all other standard therapies have been exhausted or have failed. Second, your health insurance company must approve the prescription.
Getting Reimbursed by Health Insurance
National Health Insurance
If you have national health insurance in Germany, you may be eligible to get reimbursed for the cost of your medical cannabis. However, there are some specific requirements that must be met in order to qualify for reimbursement.
First, your doctor must certify that you have a serious illness and that all other standard therapies have been exhausted or have failed. Second, your health insurance company must approve the prescription.